Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parkinson's Disease

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    August 2019
  1. MARIN-LAHOZ J, Sampedro F, Martinez-Horta S, Pagonabarraga J, et al
    Depression as a risk factor for impulse control disorders in Parkinson's disease.
    Ann Neurol. 2019 Aug 15. doi: 10.1002/ana.25581.
    PubMed     Text format     Abstract available


  2. DEMBEK TA, Roediger J, Horn A, Reker P, et al
    Probabilistic Sweetspots Predict Motor Outcome for DBS in Parkinson's Disease.
    Ann Neurol. 2019 Aug 3. doi: 10.1002/ana.25567.
    PubMed     Text format     Abstract available


    July 2019
  3. GROZDANOV V, Bousset L, Hoffmeister M, Bliederhaeuser C, et al
    Increased immune activation by pathologic alpha-synuclein in Parkinson's Disease.
    Ann Neurol. 2019 Jul 25. doi: 10.1002/ana.25557.
    PubMed     Text format     Abstract available


  4. DEL DIN S, Elshehabi M, Galna B, Hobert M, et al
    Gait analysis with wearables predicts conversion to Parkinson's disease.
    Ann Neurol. 2019 Jul 11. doi: 10.1002/ana.25548.
    PubMed     Text format     Abstract available


    June 2019
  5. VOLLSTEDT EJ, Kasten M, Klein C
    Using global team science to identify genetic Parkinson's disease worldwide.
    Ann Neurol. 2019 Jun 2. doi: 10.1002/ana.25514.
    PubMed     Text format    


  6. SAIKI S, Sasazawa Y, Fujimaki M, Kamagata K, et al
    A metabolic profile of polyamines in Parkinson's disease: a promising biomarker.
    Ann Neurol. 2019 Jun 2. doi: 10.1002/ana.25516.
    PubMed     Text format     Abstract available


    April 2019
  7. SCHULZ J, Takousis P, Wohlers I, Itua IOG, et al
    Meta-analyses identify differentially expressed microRNAs in Parkinson's disease.
    Ann Neurol. 2019 Apr 16. doi: 10.1002/ana.25490.
    PubMed     Text format     Abstract available


  8. WESTENBERGER A, Reyes CJ, Saranza G, Dobricic V, et al
    A hexanucleotide repeat modifies expressivity of X-linked dystonia-parkinsonism.
    Ann Neurol. 2019 Apr 11. doi: 10.1002/ana.25488.
    PubMed     Text format     Abstract available


  9. TROPEA TF, Mak J, Guo MH, Xie SX, et al
    TMEM106B Effect on Cognition in Parkinson's Disease and Frontotemporal Dementia.
    Ann Neurol. 2019 Apr 11. doi: 10.1002/ana.25486.
    PubMed     Text format     Abstract available


    March 2019
  10. SCHREINER SJ, Imbach LL, Werth E, Poryazova R, et al
    Slow-wave sleep and motor progression in Parkinson disease.
    Ann Neurol. 2019 Mar 18. doi: 10.1002/ana.25459.
    PubMed     Text format     Abstract available


    February 2019
  11. CHRISTINE CW, Bankiewicz KS, Van Laar AD, Richardson RM, et al
    MRI-guided Phase 1 Trial of Putaminal AADC Gene Therapy for Parkinson's Disease.
    Ann Neurol. 2019 Feb 25. doi: 10.1002/ana.25450.
    PubMed     Text format     Abstract available


  12. VAN RUMUND A, Green AJ, Fairfoul G, Esselink RA, et al
    Alpha-synuclein RT-QuIC in the CSF of uncertain cases of parkinsonism.
    Ann Neurol. 2019 Feb 23. doi: 10.1002/ana.25447.
    PubMed     Text format     Abstract available


  13. GOLDMAN SM, Marek K, Ottman R, Meng C, et al
    Concordance for Parkinson's Disease in Twins: a 20-Year Update.
    Ann Neurol. 2019 Feb 20. doi: 10.1002/ana.25441.
    PubMed     Text format     Abstract available


  14. BAKSHI R, Macklin EA, Logan R, Zorlu MM, et al
    Higher urate in LRRK2 mutation carriers resistant to Parkinson's disease.
    Ann Neurol. 2019 Feb 13. doi: 10.1002/ana.25436.
    PubMed     Text format     Abstract available


  15. BOHNEN NI, Kanel P, Zhou Z, Koeppe RA, et al
    Cholinergic system changes of falls and freezing of gait in Parkinson disease.
    Ann Neurol. 2019 Feb 5. doi: 10.1002/ana.25430.
    PubMed     Text format     Abstract available


    November 2018
  16. DU G, Lewis MM, Sica C, Kong L, et al
    Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson's disease.
    Ann Neurol. 2018 Nov 8. doi: 10.1002/ana.25376.
    PubMed     Text format     Abstract available


    October 2018
  17. ESPAY AJ, Morgante F, Merola A, Fasano A, et al
    Levodopa-induced dyskinesia in Parkinson disease: Current and Evolving Concepts.
    Ann Neurol. 2018 Oct 24. doi: 10.1002/ana.25364.
    PubMed     Text format     Abstract available


  18. AMATO N, Manconi M, Moller JC, Sarasso S, et al
    Levodopa-induced dyskinesia in Parkinson's disease: sleep matters.
    Ann Neurol. 2018 Oct 17. doi: 10.1002/ana.25360.
    PubMed     Text format     Abstract available


    September 2018
  19. SEARLES NIELSEN S, Gross A, Camacho-Soto A, Willis AW, et al
    beta2-adrenoreceptor medications and risk of Parkinson disease.
    Ann Neurol. 2018 Sep 17. doi: 10.1002/ana.25341.
    PubMed     Text format     Abstract available


    August 2018
  20. PIHLSTROM L, Blauwendraat C, Cappelletti C, Berge-Seidl V, et al
    A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.
    Ann Neurol. 2018 Aug 26. doi: 10.1002/ana.25274.
    PubMed     Text format     Abstract available


    July 2018
  21. KIA DA, Noyce AJ, White J, Speed D, et al
    Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease.
    Ann Neurol. 2018 Jul 16. doi: 10.1002/ana.25294.
    PubMed     Text format     Abstract available


  22. KOBYLECKI CJ, Nordestgaard BG, Afzal S
    Plasma urate and risk of Parkinson's disease: a Mendelian randomization study.
    Ann Neurol. 2018 Jul 16. doi: 10.1002/ana.25292.
    PubMed     Text format     Abstract available


    May 2018
  23. LUKIC S, Bisevac B, Krstic N
    Intriguing association of Parkinson disease and epileptic seizures.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25257.
    PubMed     Text format    


  24. GRUNTZ K, Fuhr P, Meier C, Ruegg S, et al
    Reply to <<Intriguing association of Parkinson disease and epileptic seizures >>.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25252.
    PubMed     Text format    


    April 2018
  25. KOTAGAL V, Spino C, Bohnen NI, Koeppe RA, et al
    Serotonin, beta-amyloid, and cognition in Parkinson disease.
    Ann Neurol. 2018 Apr 17. doi: 10.1002/ana.25236.
    PubMed     Text format     Abstract available


    March 2018
  26. JONIKAS M, Madill M, Mathy A, Zekoll T, et al
    Stem Cell modeling of Mitochondrial Parkinsonism reveals key functions of OPA1.
    Ann Neurol. 2018 Mar 31. doi: 10.1002/ana.25221.
    PubMed     Text format     Abstract available


    January 2018
  27. GRUNTZ K, Bloechliger M, Becker C, Jick SS, et al
    Parkinson's disease and the risk of epileptic seizures.
    Ann Neurol. 2018 Jan 25. doi: 10.1002/ana.25157.
    PubMed     Text format     Abstract available


    November 2017
  28. KAASINEN V, Vahlberg T
    Striatal dopamine in Parkinson's disease: A meta-analysis of imaging studies.
    Ann Neurol. 2017 Nov 22. doi: 10.1002/ana.25103.
    PubMed     Text format     Abstract available


  29. BURY AG, Pyle A, Elson JL, Greaves L, et al
    Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson's.
    Ann Neurol. 2017 Nov 17. doi: 10.1002/ana.25099.
    PubMed     Text format     Abstract available


    October 2017
  30. LEE Y, Oh JS, Chung SJ, Chung SJ, et al
    Does Smoking Impact Dopamine Neuronal Loss in de novo Parkinson's Disease?
    Ann Neurol. 2017 Oct 23. doi: 10.1002/ana.25082.
    PubMed     Text format    


  31. CAMACHO-SOTO A, Warden MN, Searles Nielsen S, Salter A, et al
    Traumatic Brain Injury in the Prodromal Period of Parkinson Disease: A Large Epidemiological Study Using Medicare Data.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25074.
    PubMed     Text format     Abstract available


  32. CHUANG YH, Lee PC, Vlaar T, Mulot C, et al
    Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson's disease.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25065.
    PubMed     Text format     Abstract available


  33. SCHONHAUT DR, McMillan CT, Spina S, Dickerson BC, et al
    18 F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25060.
    PubMed     Text format     Abstract available


    September 2017
  34. STORZER L, Butz M, Hirschmann J, Abbasi O, et al
    Bicycling suppresses abnormal beta synchrony in the Parkinsonian basal ganglia.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25047.
    PubMed     Text format     Abstract available


  35. STRANIERO L, Guella I, Cilia R, Parkkinen L, et al
    DNAJC12 and dopa-responsive non-progressive Parkinsonism.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25048.
    PubMed     Text format     Abstract available


    August 2017
  36. IRANZO A, Santamaria J, Valldeoriola F, Serradell M, et al
    Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic REM sleep behavior disorder.
    Ann Neurol. 2017 Aug 22. doi: 10.1002/ana.25026.
    PubMed     Text format     Abstract available


    June 2017
  37. HORN A, Reich M, Vorwerk J, Li N, et al
    Connectivity predicts deep brain stimulation outcome in Parkinson's disease.
    Ann Neurol. 2017 Jun 6. doi: 10.1002/ana.24974.
    PubMed     Text format     Abstract available


    May 2017
  38. MUSACCHIO T, Rebenstorff M, Fluri F, Brotchie JM, et al
    STN-DBS is neuroprotective in the A53T alpha-synuclein Parkinson's disease rat model.
    Ann Neurol. 2017 May 3. doi: 10.1002/ana.24947.
    PubMed     Text format     Abstract available


    April 2017
  39. SEIDEL K, Bouzrou M, Heidemann N, Kruger R, et al
    Involvement of the cerebellum in Parkinson's disease and Dementia with Lewy bodies.
    Ann Neurol. 2017 Apr 25. doi: 10.1002/ana.24937.
    PubMed     Text format     Abstract available


    March 2017
  40. CHEN X, Chen H, Cai W, Maguire M, et al
    The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival.
    Ann Neurol. 2017;81:395-406.
    PubMed     Text format     Abstract available


    February 2017
  41. KAUFMANN H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, et al
    Natural history of pure autonomic failure: A United States prospective cohort.
    Ann Neurol. 2017;81:287-297.
    PubMed     Text format     Abstract available


    January 2017
  42. KORDOWER JH, Goetz CG, Chu Y, Halliday GM, et al
    Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
    Ann Neurol. 2017;81:46-57.
    PubMed     Text format     Abstract available


    December 2016
  43. PAGANO G, Niccolini F, Fusar-Poli P, Politis M, et al
    Serotonin transporter in Parkinson's disease: A meta-analysis of PET studies.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24859.
    PubMed     Text format     Abstract available


  44. BRAKEDAL B, Haugarvoll K, Tzoulis C
    Simvastatin is associated with decreased risk of Parkinson Disease.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24857.
    PubMed     Text format    


  45. YEN SJ, Lin KD
    Reply to "Simvastatin is associated with decreased risk of Parkinson Disease" by Brage Brakedal.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24862.
    PubMed     Text format    


    October 2016
  46. LIN KD, Shin SJ
    Reply to 'Risk reduction of Parkinson disease by statin therapy in patients with diabetes' by T. Kawada.
    Ann Neurol. 2016 Oct 31. doi: 10.1002/ana.24813.
    PubMed     Text format    


  47. KAWADA T
    Risk reduction of Parkinson disease by statin therapy in patients with diabetes.
    Ann Neurol. 2016 Oct 27. doi: 10.1002/ana.24809.
    PubMed     Text format    


  48. STANDAERT DG, Geldmacher DS
    GBA, Parkinson disease, and the "senses and intellect".
    Ann Neurol. 2016 Oct 25. doi: 10.1002/ana.24808.
    PubMed     Text format    


  49. INZELBERG R, Flash S, Friedman E, Azizi E, et al
    Cutaneous malignant melanoma and Parkinson's disease: common pathways?
    Ann Neurol. 2016 Oct 19. doi: 10.1002/ana.24802.
    PubMed     Text format     Abstract available


    September 2016
  50. LIU G, Boot B, Locascio JJ, Jansen IE, et al
    Neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.
    Ann Neurol. 2016 Sep 22. doi: 10.1002/ana.24781.
    PubMed     Text format     Abstract available


  51. CILIA R, Tunesi S, Marotta G, Cereda E, et al
    Survival and dementia in GBA-associated Parkinson Disease: The mutation matters.
    Ann Neurol. 2016 Sep 15. doi: 10.1002/ana.24777.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: